drugset / Trial / NCT01294007
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.
Timeline
- Start
- 2011-02
- Primary completion
- 2013-11
- Completion
- 2013-11
Outcome
Outcome not reported
Stopped: “Product no longer on the market”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PureGen Osteoprogenitor Cell Allograft | Cell therapy | — | — |